Dr. Yu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3901 RAINBOW BLVD
Ms 3002
Kansas City, KS 66160Phone+1 913-588-6074Fax+1 913-588-3867
Summary
- Alan Yu, M.B., B.Chir. is Director of the Division of Nephrology and Hypertension and The Kidney Institute at the University of Kansas Medical Center. He is also the Harry Statland and Solon Summerfield Endowed Professor of Medicine at the University of Kansas. Dr. Yu received his medical degree from the University of Cambridge, England and completed his internship and residency in internal medicine, and clinical and research fellowships in nephrology at the Brigham and Women's Hospital, Harvard Medical School. He is an elected member of the American Society of Clinical Investigation and a Fellow of the American College of Physicians.
Dr. Yu's primary research interests are in kidney physiology, epithelial cell biology, and translational research in polycystic kidney disease (PKD). He is the PI on three NIH-funded clinical studies in PKD and Director of the Clinical Research Core for the NIH-funded Kansas PKD Research and Translation Core Center. Dr. Yu has published over 100 scientific papers, chapters and reviews.
Dr. Yu's clinical interests are in general nephrology, with a focus on fluid, electrolyte and acid-base disorders. He is a highly regarded teacher of fluid, electrolytes and acid-base, and has given lectures throughout the world, including teaching at the Harvard Medical School/Brigham Renal Board Review course annually for the past 20 years. He is an editor of "Brenner & Rector's The Kidney", the best-selling nephrology reference book worldwide.
Education & Training
- Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1995 - 1996
- Brigham and Women's HospitalResidency, Internal Medicine, 1992 - 1995
- School of Clinical Medicine, University of CambridgeClass of 1989
Certifications & Licensure
- CA State Medical License 2002 - Present
- KS State Medical License 2011 - 2025
- MO State Medical License 2021 - 2025
- MA State Medical License 1995 - 2003
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2016
- Fellow of American College of Physicians American College of Physicians, 2015
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- Join now to see all
Clinical Trials
- Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- Prospects for gene therapy in polycystic kidney disease.Anubhav Chakraborty, Alan S L Yu
Current Opinion in Nephrology and Hypertension. 2025-01-01 - Paracellular Transport and Renal Tubule Calcium Handling: Emerging Roles in Kidney Stone Disease.Alan S L Yu, Joshua N Curry
Journal of the American Society of Nephrology. 2024-12-01 - Treatment of Autosomal Dominant Polycystic Kidney Disease.Sara S Jdiaa, Reem A Mustafa, Alan S L Yu
American Journal of Kidney Diseases. 2024-10-16
Authored Content
- Magnesium Handling in the KidneyMay 2018
- Magnesium Handling in the KidneyMay 2018
- Total Kidney Volume in ADPKD Predicts CKD ProgressionJanuary 2018
Press Mentions
- Why Black and Latino People Still Lag on COVID Vaccines — and How to Fix ItApril 26th, 2021
- Do Less HarmJuly 10th, 2020
- Notch4 Activation Aggravates NF-κB-Mediated Inflammation in HIV-1-Associated NephropathyDecember 17th, 2019
Other Languages
- Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: